Posts

Showing posts from August, 2021

Why participate in a clinical trial?

Image
There are many reasons why people choose to join a clinical trial. Some join a Clinical trial because the treatments they have tried for their health problem did not work. Others participate because there is no treatment for their health problem. By being part of a clinical trial, participants may discern new treatments before they are widely available. Some studies are designed for, or include, people who are healthy but want to help find ways to prevent disease, such as one that may be common in their family. Many people say participating in a clinical trial is a way to play a more active role in their health care. Other people say they want to help researchers learn more about definite health problems. Whatever the motivation, when you choose to participate in a clinical trial, you become a partner in scientific discovery. And, your contribution can help future generations lead healthier lives. Major medical breakthroughs could not happen without the generosity of clinical trial par

5 patient-centric steps to boost clinical trial recruitment

R ecruiting patients for clinical trials is notoriously difficult. The results of  a recent survey conducted by the Clinical Trials transformation Initiative (CTTI) showed that protocol related and clinician-related issues are significant barriers to recruitment; however, patient related barriers also majorly affect the success or failure of clinical enrolment. Obstacles include patient perceptions and information about clinical trials, lack of awareness about opportunities to take part in trials, concerns about placebos, travel time and trial related expenses. Additional research indicates that sponsors, contract research organisations (CROs) and clinical study sites should proactively address these patient-related barriers before starting any new clinical trials. There are five core, practical steps that can be taken to help foster patient-focused participation. 1) Develop patient centred trial designs-  By focusing on the long-term availability of patients at the start of the study,